• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Mark P. Callery, FACS, MD


  • Lee MK, Lewis RS, Strasberg SM, Hall BL, Allendorf JD, Beane JD, Behrman SW, Callery MP, Christein JD, Drebin JA, Epelboym I, He J, Pitt HA, Winslow E, Wolfgang C, Vollmer CM.Defining the post-operative morbidity index for distal pancreatectomy.Hpb : The Official Journal Of The International Hepato Pancreato Biliary Association. 2014 Jun 16.
  • Bliss LA, Yang CJ, Chau Z, Ng SC, McFadden DW, Kent TS, Moser AJ, Callery MP, Tseng JF.Patient selection and the volume effect in pancreatic surgery: unequal benefits?.Hpb : The Official Journal Of The International Hepato Pancreato Biliary Association. 2014 Jun 6.
  • Miller BC, Christein JD, Behrman SW, Drebin JA, Pratt WB, Callery MP, Vollmer CM.A multi-institutional external validation of the fistula risk score for pancreatoduodenectomy.J Gastrointest Surg. 2014 Jan;18(1):172-79; discussion 179-80.
  • Chau Z, West JK, Zhou Z, McDade T, Smith JK, Ng SC, Kent TS, Callery MP, Moser AJ, Tseng JF.Rankings versus reality in pancreatic cancer surgery: a real-world comparison.Hpb : The Official Journal Of The International Hepato Pancreato Biliary Association. 2013 Nov 7.
  • Miller BC, Christein JD, Behrman SW, Callery MP, Drebin JA, Kent TS, Pratt WB, Lewis RS, Vollmer CM.Assessing the impact of a fistula after a pancreaticoduodenectomy using the Post-operative Morbidity Index.Hpb : The Official Journal Of The International Hepato Pancreato Biliary Association. 2013 Oct;15(10):781-8.
  • NĂ­ Mhuircheartaigh JM, Sun MR, Callery MP, Siewert B, Vollmer CM, Kane RA.Pancreatic surgery: a multidisciplinary assessment of the value of intraoperative US.Radiology. 2013 Mar;266(3):945-55.
  • Ragulin-Coyne E, Witkowski ER, Chau Z, Ng SC, Santry HP, Callery MP, Shah SA, Tseng JF.Is routine intraoperative cholangiogram necessary in the twenty-first century? A national view.J Gastrointest Surg. 2013 Mar;17(3):434-42.
  • Lewis R, Drebin JA, Callery MP, Fraker D, Kent TS, Gates J, Vollmer CM.A contemporary analysis of survival for resected pancreatic ductal adenocarcinoma.Hpb : The Official Journal Of The International Hepato Pancreato Biliary Association. 2013 Jan;15(1):49-60.
  • Kent TS, Jr CM, Callery MP.Intraductal papillary mucinous neoplasm and the pancreatic incidentaloma.World J Gastrointest Surg. 2010 Oct 27;2(10):319-23.
  • Mahadevan A, Jain S, Goldstein M, Miksad R, Pleskow D, Sawhney M, Brennan D, Callery M, Vollmer C.Stereotactic Body Radiotherapy and Gemcitabine for Locally Advanced Pancreatic Cancer.Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):735-42.
  • Kent TS, Raptopoulos V, Callery MP, Gautam S, Vollmer CM.Escalating computed tomography angiogram (CTA) grade predicts unresectability and margin status for pancreaticobiliary neoplasms.Hpb : The Official Journal Of The International Hepato Pancreato Biliary Association. 2010 Mar;12(2):115-22.
  • Sawhney MS, Al-Bashir S, Cury MS, Brown A, Chuttani R, Pleskow DK, Callery MP, Vollmer CM.International consensus guidelines for surgical resection of mucinous neoplasms cannot be applied to all cystic lesions of the pancreas.Clin Gastroenterol Hepatol. 2009 Dec;7(12):1373-6.
  • Pratt WB, Gangavati A, Agarwal K, Schreiber R, Lipsitz LA, Callery MP, Vollmer CM.Establishing standards of quality for elderly patients undergoing pancreatic resection.Arch Surg. 2009 Oct;144(10):950-6.
  • Cannon JW, Callery MP, Vollmer CM.Diagnosis and management of pancreatic pseudocysts: what is the evidence?.J Am Coll Surg. 2009 Sep;209(3):385-93. Review.
  • Demirjian AN, Vollmer CM, McDermott DF, Mullen JT, Atkins MB, Callery MP.Refining indications for contemporary surgical treatment of renal cell carcinoma metastatic to the pancreas.Hpb : The Official Journal Of The International Hepato Pancreato Biliary Association. 2009;11(2):150-3.
  • Pratt WB, Vollmer CM, Callery MP.Outcomes in pancreatic resection are negatively influenced by pre-operative hospitalization.Hpb : The Official Journal Of The International Hepato Pancreato Biliary Association. 2009;11(1):57-65.
  • Callery MP,Chang KJ,Fishman EK,Talamonti MS,William Traverso L,Linehan DC.Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement.Ann Surg Oncol. 2009 Jul;16(7):1727-33.
  • Sachs T,Pratt WB,Callery MP,Vollmer CM Jr.The incidental asymptomatic pancreatic lesion: nuisance or threat?.J Gastrointest Surg. 2009 Mar;13(3):405-15.
  • Callery MP,Pratt WB,Vollmer CM Jr.Prevention and management of pancreatic fistula.J Gastrointest Surg. 2009 Jan;13(1):163-73. Review.
  • Callery MP, Freedman SD.A 21-year-old man with chronic pancreatitis.JAMA. 2008 Apr 2;299(13):1588-94.
  • Callery MP.Risk-adjusted outcomes analysis: leveling the field in health care quality.Gastroenterology. 2008 Feb;134(2):632-4.
  • Pratt WB, Callery MP, Vollmer CM Jr.Risk prediction for development of pancreatic fistula using the ISGPF classification scheme.World J Surg. 2008 Mar;32(3):419-28.
  • Pratt W, Joseph S, Callery MP, Vollmer CM Jr.POSSUM accurately predicts morbidity for pancreatic resection.Surgery. 2008 Jan;143(1):8-19.
  • Zamboni GA, Kruskal JB, Vollmer CM, Baptista J, Callery MP, Raptopoulos VD.Pancreatic adenocarcinoma: value of multidetector CT angiography in preoperative evaluation.Radiology. 2007 Dec;245(3):770-8.
  • Moss AC, Callery MP, Falchuk KR.Gastrointestinal [corrected] stromal tumor of the ampulla of vater mimicking a duodenal ulcer.Clin Gastroenterol Hepatol. 2007 Oct;5(10):A26.
  • Vanounou T, Pratt WB, Callery MP, Vollmer CM Jr.Selective administration of prophylactic octreotide during pancreaticoduodenectomy: a clinical and cost-benefit analysis in low- and high-risk glands.J Am Coll Surg. 2007 Oct;205(4):546-57.
  • Callery MP.Biological therapies for pancreatic cancer.Gastroenterology. 2007 Jun;132(7):2607-8; discussion 2608-9.
  • Freedman SD, Callery MP.Central control of pancreatic cancer pain: protecting the enemy?.Gastroenterology. 2007 Mar;132(3):1191-2.
  • Maithel SK, Khalili K, Dixon E, Guindi M, Callery MP, Cattral MS, Taylor BR, Gallinger S, Greig PD, Grant DR, Vollmer CM.Impact of regional lymph node evaluation in staging patients with periampullary tumors.Ann Surg Oncol. 2007 Jan;14(1):202-10.
  • Callery MP.Helicobacter pylori in gastric cancer: Friend or foe?.Gastroenterology. 2006 Sep;131(3):966-7.
  • Bai J, Demirjian A, Sui J, Marasco W, Callery MP.Histone deacetylase inhibitor trichostatin A and proteasome inhibitor PS-341 synergistically induce apoptosis in pancreatic cancer cells.Biochem Biophys Res Commun. 2006 Oct 6;348(4):1245-53.
  • Callery MP.Transplantation for cholangiocarcinoma: Advance or supply-demand dilemma?.Gastroenterology. 2006 Jun;130(7):2242-4; discussion 2244.
  • Demirjian AN, Callery MP.Environment, genetics, and fish? Answers to the cancer riddle.Gastroenterology. 2006 Mar;130(3):1000-1.
  • Novitsky YW, Kercher KW, Czerniach DR, Kaban GK, Khera S, Gallagher-Dorval KA, Callery MP, Litwin DE, Kelly JJ.Advantages of mini-laparoscopic vs conventional laparoscopic cholecystectomy: results of a prospective randomized trial.Arch Surg. 2005 Dec;140(12):1178-83.
  • Callery MP.Chemotherapy-related steatohepatitis: proceed with caution.Gastroenterology. 2005 Dec;129(6):2114-5.
  • Callery MP.A new platform for gene discovery in pancreatic cancer.Gastroenterology. 2005 Aug;129(2):763-4.
  • Novitsky YW, Litwin DE, Callery MP.The net immunologic advantage of laparoscopic surgery.Surg Endosc. 2004 Oct;18(10):1411-9.
  • Bai J, Sui J, Demirjian A, Vollmer CM, Marasco W, Callery MP.Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro.Cancer Res. 2005 Mar 15;65(6):2344-52.
  • Callery MP.Laparoscopic colectomy for colon cancer: new answers, new questions.Gastroenterology. 2005 Mar;128(3):793-4.
  • Shah SA, Potter MW, Hedeshian MH, Kim RD, Chari RS, Callery MP.PI-3' kinase and NF-kappaB cross-signaling in human pancreatic cancer cells.J Gastrointest Surg. 2001 Nov-Dec;5(6):603-12; discussion 612-3.
  • Shah SA, Potter MW, Callery MP.Ubiquitin proteasome pathway: implications and advances in cancer therapy.Surg Oncol. 2001 Jul-Aug;10(1-2):43-52.
  • Shah SA, Potter MW, McDade TP, Ricciardi R, Perugini RA, Elliott PJ, Adams J, Callery MP.26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer.J Cell Biochem. 2001 Apr 2-27;82(1):110-22.